Intelligence · Patent portfolio
LEXICON PHARMACEUTICALS Patents
Full USPTO pharma patent portfolio for LEXICON PHARMACEUTICALS — grant dates, expiration, and drug cross-links.
- Patents
- 102
- Expiring ≤24m
- 4
Quick answer
LEXICON PHARMACEUTICALS has 102 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.
-
US 12344596
Solid forms of (S)-1-((2′,6-bis(difluoromethyl)-[2,4′-bipyridin]-5-yl)oxy)-2,4-dimethylpentan-2-amine and salts thereof
granted -
US 11730723
Compounds and methods for treating viral infections
granted -
US 11666575
Pyrazolo[1,5]pyrimidine-based compounds and methods of their use to treat viral infections
granted -
US 11059907
Antibodies that bind Notum Pectinacetylesterase
granted -
US 10106569
Inhibitors of sodium glucose transporter 1 for constipation
granted -
US 9862724
Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
granted -
US 9688710
Inhibitors of sodium glucose cotransporter 1
granted -
US 9682982
Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use
granted -
US 9624238
4H-thieno[3,2-C]chromene-based inhibitors of Notum Pectinacetylesterase and methods of their use
granted -
US 9403832
Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
granted -
US 9365602
Sodium glucose co-transporter inhibitors and methods of their use
granted -
US 9200025
Inhibitors of sodium glucose cotransporter 1
granted -
US 9067962
Methods of treating diabetes
granted -
US 8969565
Imidazo[1,2-b]pyridazine-based compounds, compositions comprising them, and methods of their use
granted -
US 8946415
Pyrazolo[1,5-a]pyrimidine-based compounds, compositions comprising them, and methods of their use
granted -
US 8772483
Solid forms of (S)-2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid
granted -
US 8772291
Multicyclic compounds and methods of their use
granted -
US 8772482
4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
granted -
US 8742075
Monoclonal antibodies against ANGPTL3
granted -
US 8735408
Solid forms of 3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate
granted -
US 8658682
(E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone dihydrate and methods of its use
granted -
US 8653094
Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)-pyrimidin-4-yl)phenyl)propanoate and methods of their use
granted -
US 8629156
Tryptophan hydroxylase inhibitors
granted -
US 8591891
Monoclonal antibodies against ANGPTL4
granted -
US 8507672
Substituted pyrrolo[2,3-d]pyrimidines as LIM kinase 2 inhibitors
granted -
US 8497271
Modulators of G protein-coupled receptor 88
granted -
US 8476413
Sulfanyl-tetrahydropyran-based compounds and methods of their use
granted -
US 8450332
LIMK2 inhibitors, compositions comprising them, and methods of their use
granted -
US 8450532
Compounds useful in the preparation of tryptophan hydroxylase inhibitors
granted -
US 8440652
MST1 kinase inhibitors and methods of their use
granted -
US 8426414
Modulators of G protein-coupled receptor 88
granted -
US 8410121
Methods of treating pulmonary hypertension
granted -
US 8404732
Methods of treating ulcerative colitis
granted -
US 8304577
Modulators of G protein-coupled receptor 88
granted -
US 8293878
Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
granted -
US 8227661
Methods of identifying agents that ameliorate or modulate effects of PRO1328 gene disruptions
granted -
US 8217156
Solid forms of (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol and methods of their use
granted -
US 8193204
Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use
granted -
US 8193202
LIMK2 inhibitors, compositions comprising them, and methods of their use
granted -
US 8153804
Aryl pyridines and methods of their use
granted -
US 8093246
O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer
granted -
US 8092796
Monoclonal antibodies against ANGPTL4
granted -
US 8093267
Methods of treating rheumatoid arthritis
granted -
US 8093280
Methods of preparing imidazole-based compounds
granted -
US 8093245
4-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their use
granted -
US 8093291
Methods of using and compositions comprising tryptophan hydroxylase inhibitors
granted -
US 8063057
Multicyclic amino acid derivatives and methods of their use
granted -
US 8026347
Methods and compounds useful for the preparation of sodium glucose co-transporter 2 inhibitors
granted
Frequently asked questions
How many patents does LEXICON PHARMACEUTICALS have?
102 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do LEXICON PHARMACEUTICALS patents expire?
4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources · Patent directory